Isabella Worlewenut Paulsen

Isabella Worlewenut Paulsen

Auto-generated profile, based on publicly available information

Isabella Worlewenut Paulsen

Department of Clinical Immunology, Naestved Hospital, Naestved, Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSteffen Jørgensen
Steffen Jørgensen
IPIsabella Worlewenut Paulsen
Isabella Worlewenut Paulsen
JHJakob Werner Hansen
Jakob Werner Hansen
DTDorte Tholstrup
Dorte Tholstrup
CHChristoffer Hother
Christoffer Hother
OPOle Birger Vesterager Pedersen
Ole Birger Vesterager Pedersen
MicroRNAs are small regulatory RNAs that are deregulated in a wide variety of human cancers, including different types of B-cell lymphoma. Nevertheless, the feasibility of circulating microRNA for early diagnosis of B-cell lymphoma has not been established. To address the possibility of detecting specific circulating microRNAs years before a B-cell lymphoma is diagnosed, we studied the plasma expression of microRNA first in pre-treatment samples from patients with diffuse large B-cell lymphoma and subsequently in repository samples from blood donors who later developed B-cell lymphomas. In addition, we studied the microRNA expression in the diagnostic lymphoma biopsy. The most strongly induced (miR-326) and suppressed (miR-375) plasma microRNA at diagnosis, when compared with healthy blood donors, were also substantially up- or down-regulated in plasma repository samples taken from several months to up to two years before the blood donors were diagnosed with B-cell lymphoma. Importantly, at these time points the donors had no signs of disease and felt healthy enough to donate blood. In conclusion, this first study of plasma microRNA profiles from apparently healthy individuals, taken several years before B-cell lymphoma diagnosis, suggests that plasma microRNA profiles may be predictive of lymphoma development.